It directly effected proliferation and apoptosis of DLBCL cells by enhancing the expression of p21CIP1 genes and promoted tumor cells to display resistance to chemotherapeutic drugs. The gene discussed is CDKN1A; the disease is diffuse large B-cell lymphoma.